Clinical Trial Update: Multiprofen-CC™ to Reduce Pain After Total Knee Arthroplasty [Phase 3]

View source ↗

Summary

Phase 3 trial update for Multiprofen-CC™ investigating pain reduction after total knee arthroplasty has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee
• Postsurgical Pain
• Total Knee Arthroplasty-related Pain

Drugs mentioned

• Multiprofen-CC

Snippet

Sponsor: KAZM Pharmaceuticals Inc. | Conditions: Postsurgical Pain | Phase 3 | Status: COMPLETED